drugset / Trial / NCT01925261

A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees

NCT01925261 ↗

Phase 2 Completed 120 enrolled OrthoTrophix, Inc
RandomizedFactorialQuadruple-blindTreatment

Summary

This one-year study is designed to investigate the safety and efficacy of TPX-100, a 23-amino acid chondrogenic peptide, delivered by intra-articular injection, in regeneration of knee cartilage in subjects with bilateral osteoarthritis of the knee.

Timeline

Start
2014-01
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator TPX-100 Peptide 20 mg Intrathecal
Comparator TPX-100 Peptide 50 mg Intrathecal
Comparator TPX-100 Peptide 100 mg Intrathecal
Comparator TPX-100 Peptide 200 mg Intrathecal

Indications